Navigation Links
DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
Date:6/16/2009

iewed Investigational New Drug (IND) Applications and New Drug Applications (NDAs) for opiate, non-opiate, anti-inflammatory, and novel pain compounds.

Dr. Stauffer is a founding member of the Initiative on Methods, Measurement and Pain Assessment in Clinical Trials (IMMPACT). This on-going collaboration between pharma, FDA, NIH, academia and patient advocacy groups helps to develop core domains and outcomes for chronic pain clinical trials. Dr. Stauffer graduated from the Philadelphia College of Osteopathic Medicine and completed residency training in Anesthesiology at the Johns Hopkins University Hospital, where he is currently an Adjunct Assistant Professor in the Department of Anesthesiology and Critical Care Medicine. Dr. Stauffer is a veteran of the U.S. Navy, honorably discharged as a Lieutenant Commander after serving eight years as a Naval Medical Officer. He will complete his MBA in September 2009 as part of the TRIUM Global Executive MBA Program, a joint degree granted by NYU Stern School of Business, HEC School of Management (Paris) and the London School of Economics and Political Science.

"I should also note that Dr. Peter Langecker, DURECT's former Chief Medical Officer, has resigned from DURECT Corporation to pursue another opportunity," stated James E. Brown. "We want to thank Peter for his service to DURECT and wish him well on his future endeavors."

About DURECT Corporation

DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY(R), POSIDUR(TM), ELADUR(TM), and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for
'/>"/>

SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
2. DURECT to Present at UBS Global Life Sciences Conference
3. DURECT to Present at 2007 BIO Investor Forum
4. DURECT to Present at BIO CEO Investor Conference 2008
5. DURECT to Participate in Susquehanna Financial Healthcare Conference
6. DURECT to Participate in Cowen Annual Healthcare Conference
7. DURECT Provides Update on CHRONOGESIC(R) Research Program
8. DURECT to Participate in Morgan Stanley Global Healthcare Conference
9. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
10. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
11. DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Balance, Inc. (Nasdaq: SMBL ) announced today that ... repurchase program of up to $25 million, to begin ... we have in the prospects of our Company and ... of our shareholders, while at the same time making ... Inc. Chairman and Chief Executive Officer. ,, Any purchases ...
(Date:12/16/2009)... 16, 2009 -- Every year in the United States, ... patients die of the disease, making it the second ... lung cancer. , As researchers and clinicians fervently look ... generating thousands of studies producing more and more promising ... cancer and genetics at Case Western Reserve University School ...
(Date:12/16/2009)... 16 Losing has never felt so good ... his healthy new lifestyle means continuing to make smart ... free milk is one healthy choice that is an ... step everyone can take. Every glass of milk has ... to help maintain normal blood pressure, and calcium and ...
(Date:12/16/2009)... ANN ARBOR, Mich., Dec. 16 The most widely ... a finding that raises social justice questions that must ... benefit from stem cell advances, according to a University ... study of its kind, the U-M team analyzed 47 ... commonly used by stem cell researchers. The scientists determined ...
(Date:12/16/2009)... is long-term goal, researchers say , , WEDNESDAY, Dec. ... to predict whether a patient will suffer a second ... "This is an important new tool because studies have ... after a first stroke are more likely to die ... General Hospital and Harvard Medical School, said in an ...
Breaking Medicine News(10 mins):Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Stroke Tool May Predict Early Recurrence 2
... company Pathfinder Business Strategies names the most powerful, yet underutilized tax ... ... 12, 2009 -- Aftershocks from the United States, current financial crisis ... for years to come. Among the most vulnerable who have a ...
... an exciting move, Dr. Gavin Chan of the Victorian Cosmetic Institute has ... at the Templestowe clinic within two to three months, Dr. Chan expects ... months. , ... Melbourne, Victoria (PRWEB) March 12, 2009 -- In an ...
... Service Makes Offer to Support March for Babies(R)WHITE PLAINS, N.Y., ... more at participating locations* to the March of Dimes on ... Funds raised will support March for Babies, the annual event ... a healthy start in life. For the second year, ...
... 11 MedQuist Inc., (Nasdaq: MEDQ ) ... world, today announced its financial results for its full ... Year Results , Net revenues for the year ... $340.3 million for the year ended December 31, 2007. ...
... lung, heart risks, report finds , , WEDNESDAY, March 11 (HealthDay ... lung disease caused by atmospheric ozone, a new study finds. ... hot, dry cities such as Los Angeles, which has one ... may face a 25 percent to 30 percent higher annual ...
... Taking Control of Your Diabetes (TCOYD) conference and health ... Hawaii Convention Center, bringing national and local medical experts ... diabetes, those at risk for diabetes, and their loved ... programs.Leading specialists will discuss practical advice and developments in ...
Other Medicine News:Health News:Top 20 Tax Tips For Doctors 2Health News:Victorian Cosmetic Institute to offer Liposuction Treatments 2Health News:Get Free Tax Preparation With Donation to Help Babies 2Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 2Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 3Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 4Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 5Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 6Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 7Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 8Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 9Health News:MedQuist Reports Fourth Quarter and Year End 2008 Results 10Health News:Ozone Pollution Taking Toll on American Lives 2Health News:Ozone Pollution Taking Toll on American Lives 3Health News:Taking Control of Your Diabetes Conference Returns to Hawaii to Bring Answers, Advocacy and Hope for People with Diabetes 2
(Date:12/16/2009)... A new application developed by ... review of specialty pharmaceuticals has increased health plan ... while reducing costs. ,, AIM, a leading diagnostic ... plan clients representing over 35 million consumers and ... WLP ), adapted the successful clinical and ...
(Date:12/16/2009)... Inc. (Pink Sheets: AVXT) ("AVAX" or the "Company") ... loan financing (the "2009 Financing") pursuant to a ... with Firebird Global Master Fund, Ltd., ("Firebird"). Pursuant ... promissory note, due June 30, 2010, in the ... warrant to purchase an aggregate of 93,333,333 shares ...
(Date:12/16/2009)... -- Boston Scientific Corporation (NYSE: BSX ) ... elected Nelda Connors as a Director. ,, ... Metal Products division of Tyco International. Previously, she ... positions in operations and general management. Prior to ... executive and management capacities with Ford, Chrysler and Mogami ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3FindFloridaLawyer com Announces the Grand Opening of Its Online Attorney Search and Legal Resource Site 57360 1FindFloridaLawyer com Announces the Grand Opening of Its Online Attorney Search and Legal Resource Site 57360 2Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 1Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 2Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 3Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 4Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 5Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 6Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 7Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 ESMO 34 Congress 57358 8Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 1Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 2Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 3Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 4
... Shenzhen Chipscreen Biosciences, Ltd., and HUYA Bioscience International, ... 1 trial conducted by Chipscreen of the investigational compound ... Society of Clinical Oncology (ASCO) Annual Meeting, which will ... in Orlando, Florida. Chidamide/HBI-8000 is a novel benzamide class ...
... clinical data, competitor focus, and new drug-eluting technologies to ... , according to Millennium Research Group WALTHAM, Mass., ... European Markets for Peripheral Vascular (PV) Devices 2009 ... procedures that treat lower extremity peripheral artery disease in ...
Other Medicine Technology:Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting 2Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013 2Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013 3
Hush Puppies Pups feature vibrant colors and playful styling for children. Kids love the added comfort while parents love the durable designs found in every Hush Puppies Pups frame....
... Tura's original collection continues to be the ... designs exemplify the style of today's woman ... and durability. The lovley shapes, unique materails ... apart. Rich colors and exclusive styling enhance ...
... features a variety of colors and ... feminine styles designed with elegant jewel ... and women that are made from ... used in our fine timepieces, Timex ...
... style offers men and women updated shapes and ... feature modern shapes and easy to wear deigns ... a casual look with combinations of metal fronts ... custom Hush Puppies nosepads for added comfort and ...
Medicine Products: